PNV 1.16% $2.55 polynovo limited

A scientific breakthrough may lead to an effective anti-obesity drug, page-2

  1. 44 Posts.
    lightbulb Created with Sketch. 7
    I remember it very well moosey .
    The day metabolic announced  the results of that trial my stomach sank ....lol . Early retirement plans
    down the gurgler . I was a shareholder since 2003 and followed the AOD9604 anti obesity drug up until its failed trials . I continued to hold the shares since then .
    I have a feeling  metabolic were on the right track ,  Maybe they could have experimented with different ways to administer  AOD9604 .  Or perhaps they seen AOD9604 as a bottomless pit and they took a short
    cut .
    Who knows , maybe they actually have the antibody blocking drug in AOD9604 ., and perhaps polynovo have the way to administer the drug with the drug elution pellets .
    I think metabolic is a private company now with calzada's ex CEO running it now . but im not sure .
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.55
Change
-0.030(1.16%)
Mkt cap ! $1.760B
Open High Low Value Volume
$2.60 $2.61 $2.55 $1.647M 639.8K

Buyers (Bids)

No. Vol. Price($)
1 847 $2.55
 

Sellers (Offers)

Price($) Vol. No.
$2.56 3376 1
View Market Depth
Last trade - 16.10pm 20/08/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.